|
HS Code |
791254 |
| Chemical Name | Nandrolone undecylate |
| Brand Names | Dynabolon, Undeclynate, Anabolin Depot |
| Molecular Formula | C29H46O3 |
| Molecular Weight | 442.68 g/mol |
| Drug Class | Anabolic androgenic steroid |
| Route Of Administration | Intramuscular injection |
| Half Life | 7-12 days |
| Uses | Treatment of anemia, muscle wasting disorders |
| Appearance | Clear oily solution |
| Cas Number | 862-89-5 |
As an accredited Nandrolone Undecylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Nandrolone Undecylate features a 10ml amber glass vial, clearly labeled with compound details and a secure flip-off cap. |
| Shipping | Nandrolone Undecylate is shipped in secure, leak-proof containers compliant with international regulations for controlled substances. Packaging ensures protection from light, moisture, and temperature fluctuations. All shipments include safety documentation and labeling as required by law. Deliveries are processed via licensed couriers specializing in pharmaceutical and chemical transport, ensuring traceability and confidentiality. |
| Storage | Nandrolone Undecylate should be stored in a tightly closed container, protected from light and moisture, at a temperature between 15°C and 25°C (59°F to 77°F). Keep it away from heat, direct sunlight, and incompatible substances. Store in a secure area, out of reach of children and unauthorized personnel, to ensure safety and maintain chemical stability. |
Applications of Nandrolone Undecylate in Industrial ManufacturingNandrolone Undecylate serves as a critical raw pharmaceutical compound in several regulated production chains within the global life sciences and animal health sectors. As an active ingredient substance, its manufacturing and downstream integration require precise regulatory alignment, defined process stages, and strict adherence to international standards of quality and documentation. 1. Pharmaceutical Bulk Steroid API ProductionNandrolone Undecylate is employed as an active pharmaceutical ingredient (API) precursor in the manufacture of injectable anabolic-androgenic steroid formulations at GMP-certified sites. This process involves stringent batch control, validated synthesis, purification, and micronization following pharmacopeial monographs to ensure specification conformity for human medicinal products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Veterinary Medicine Injectable FormulationManufacturers use Nandrolone Undecylate as a potent anabolic agent within compounded veterinary injectables for livestock and large animal health management. Strict inventory controls and compliance documentation are required during production to meet regional animal drug licensing standards, with all formulations registered and batch-traceable. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Clinical Reference Standard Material SupplyAccredited laboratories and pharmaceutical quality control units source Nandrolone Undecylate reference materials for use in analytical method validation, pharmacokinetic studies, and forensic toxicology. Such reference standards must meet traceable batch purity characterizations, be accompanied by complete certificates of analysis (CoA), and align to globally harmonized analytical procedures. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Contract Manufacturing for Human Injectable Preparations (Custom Synthesis)Specialist pharmaceutical CDMOs undertake custom synthesis and fill-finish manufacturing of injectable steroids based on Nandrolone Undecylate for originator and generic product lines. This involves documented process scale-up, validated cleanroom filling, and regulatory dossier support for market submission in defined territories. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Nandrolone Undecylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing Nandrolone Undecylate sometimes feels like a challenge that pulls together the experience and technical instinct you can't find in a textbook. In our factory, every batch tells a story about changes in raw material markets, customer expectations, and, most of all, the pride of our own chemists. Here we’ll introduce Nandrolone Undecylate by speaking directly to its manufacture, specification, experience in use, and, crucially, how it stands apart from other nandrolone esters and anabolic products. Our aim: not the abstract ideal, but the daily reality behind an injectable that has shaped medical and research fields for decades.
Nandrolone Undecylate, or 19-nortestosterone undecylate, is a longer-chain ester of the nandrolone molecule. The undecylenate chain gives it both a moderate half-life and a delayed release profile once injected. We produce this compound as a clear, viscous oil that, even before laboratory confirmation, gives off cues about its purity and correct structure. Chemists on our floors use HPLC and GC analysis for every lot, but hands-on, there’s always that subtle check—the slight nutty scent, the even consistency, the absence of crystalline separation once prepared in carrier oil.
Our long-establishment of the specification starts where the literature leaves off. Nandrolone content typically falls between 97% and 101% on a dry basis. The undecylenate must bind firmly, avoiding hydrolysis during storage and transport. Residual solvents, especially the persistent ethereal traces common in pharma-grade synthesis, get attention in our plant, and we invest more than recipe calls for in vacuum drying and high-spec nitrogen-purged packaging. The color in final vials stays pale yellow, almost golden, not the deep amber that speaks to oxidation or poor filtration. These small points tell the story of a factory that doesn’t rush an active hormone into a bottle—it works it into form, checks it daily in stability trials, and runs extended impurity screenings, even during periods of high demand when skipping would be easier.
Nandrolone Undecylate stands out because it lasts in the body. Responsibility often shifts from manufacturer to healthcare professional at the point of injection, but the consequences of sloppy synthesis, contamination, or incorrect esterification always catch up. Some widely-cited references put the effective window for release at roughly 10–20 days. From our own release trials, conducted with full respect for relevant regulations, this longer presence comes from the high molecular weight of the undecylate chain, not only from depot absorption. A weakly bound or inconsistent ester transfers into unpredictable hormone release, risking both under-dosing and sudden surges. That is the reason we've developed, over years, a double-check system for ensuring consistent binding and slow, reliable release in vitro before any batch receives approval.
While end users—doctors, veterinarians, researchers—often focus on ampule size or manufacturer reputation, we view issues like solvent retention and lubricant compatibility as decisive. Some markets request compounded versions for animal use with variant carrier oils. Our data consistently demonstrates that deviations from pharmaceutical-grade sesame or cottonseed oils introduce cloudiness, slow precipitation, and even local irritation upon injection. In every batch, we perform clarity and particulate tests under controlled cold, room, and elevated temperatures to anticipate transport and field storage conditions. This isn’t just regulatory compliance, but a matter of operator pride—no one in our lab wants to hear about a shipment arriving with clumped deposits or separated layers.
Nandrolone’s relation to hemoglobin stimulation and bone mineral balance has been studied since the 1960s, and its clinical value leans on predictability—not only biological effect, but physical stability and chemical consistency lot-to-lot. Our engineers have refined our crystallization and washing steps to reduce side-chain analogs, particularly the riskier 17-epimers. Each deviation, even by a few tenths of a percent, can alter the pharmacokinetics of a depot injection. For medical professionals and researchers, this means more precise dosing and fewer surprises during studies or treatments. For us, it means that a finished vial represents months of cumulative laboratory learning and not an off-shelf synthesis.
It’s easy to lump anabolic steroids together based on their core structure, but the longer undecylate ester creates practical differences for patients and researchers. From our perspective, three main differences matter most.
Short-chain nandrolone esters like phenylpropionate or decanoate break down faster. They’re metabolized quickly in vivo, creating a need for more frequent injective dosing. This routine can increase risk of irritation at the site, needle tract complications, and patient non-compliance in long-term therapy. Undecylate—thanks to its eleven-carbon side—frees users from the sharp curve, giving both a steadier plasma concentration and fewer total injections per cycle. In practice, this means our customers report more stable user profiles and a measurable reduction in batch recalls relating to rapid breakdown or unpredictable out-dates. As we’ve moved to biological validation, we’ve documented more consistent hormone levels at extended intervals in animal models, something smaller esters fail to achieve.
Undecylate chains require more care in dissolution. Many smaller plants or resellers overlook that heating and agitation must be tightly controlled. We scale up with jacketed reactor tanks, maintaining both temperature and nitrogen blanket to prevent early oxidation or micron-scale precipitation. Our mass spectrometry logs show slightly higher retention of steroid activity with the correct (slow, heat-moderated) dispersion of the powder into carrier oil, as opposed to rapid, forced solution favored by some shortcut manufacturers. The difference isn’t just chemical purity—it’s the absence of particulates, the glass-like clarity under magnification, and a draw-syringe feel that isn't grainy or resistant. For end-users in medical trials or ongoing treatment, this translates to less discomfort, clear dosing, and lower risk of unexpected reactions from insoluble byproducts.
Long-chain esters like undecylate resist hydrolysis, meaning they retain potency and structure even in warmer climates or over extended shelf times. Our research team has tracked metrics for up to 36 months at both 2–8°C and room temperature. We’ve noticed that, compared to decanoate or smaller esters, undecylate batches rarely show visible breakdown or significant reduction in active content, even with minor temperature fluctuations in shipping or warehousing. Some batches, particularly during hotter months, have presented challenges around label adhesives or vial integrity, but the core compound remains stable long past minimum expiration dates. By contrast, shorter-chain esters in low-grade ampules break down quickly, resulting in color shifts, sediment, or even breakdown of the glass itself in extreme conditions. Our experience tells us that customers investing in undecylate receive a product with true longevity and minimal need for temperature-controlled logistics, provided that batch meets our strict standard for oxidative resistance.
The true act of manufacturing Nandrolone Undecylate starts well before the reactor fires. Finding the right grade of nandrolone precursor means building relationships over years with raw suppliers, refusing inconsistent quality, and paying attention to subtle chemical signatures that signal fresh, contaminant-free input. Small changes—a couple degrees increase in drying temperature, an hour too long in the crystallization tank, a supplier’s switch to lower-grade solvents—create outsized changes in both outcome and reproducibility.
We run weekly calibration checks on vacuum filtration and solvent distillation lines, not because regulations call for it, but because the shift foremen and experienced chemists know that drift here becomes a failed batch, or worse, a silent breakdown in product strength. All final-stage filtration is done in controlled rooms, with every filter surface logged and cross-checked to ensure that no foreign particles or unexpected residues pass through to the final vial. Our operators spend hours monitoring clarity under various lighting, a process that automation can’t fully replicate. You get that sort of skill only with seasoned technicians—a point lost on plants relying only on automated inspection.
There’s a culture here: everyone on the floor knows a batch failure ripples across the supply chain. That’s why the commitment to quality stands stronger in practice than it looks on a process chart. Any deviation, even small, leads to full rework or discard, not a blended in fix. Senior staff have veto power at every stage—the test batch, the post-dissolution stir-down, the pre-filling inspection. Each rejected lot costs, but over years of production, this approach has built the trust of researchers and buyers looking for reliability, not short-term gains.
Challenges arise constantly—some repeat, some blindside us. The two most common involve raw material purity and reaction control. Early on, we faced challenges with batch contamination from trace alkaloids in plant-based precursors, brought in by third-party suppliers. Detailed GC-MS audits and a hard-won policy of rejecting shipments without full provenance have reduced these incidents to almost none.
Temperature shifts lead to inconsistent esterification. Automated reactors help, but older batches show that experience trumps automation—timing, flow rate, and even the order of added reagents determine how well the undecylate bonds. Each failed run has led us to tighter process documentation and an internal training program for both new and veteran staff. This isn’t about sticking to theory, but taking what happened in a night shift, logging it, and turning it into practical warnings for the next crew.
Solvent and waste removal present downstream challenges. Instead of relying on continuous washing or spraying, we designed, with input from engineers who spent decades on our floor, a graduated solvent-phase cleaning that strips unwanted residues without overexposing the core compound. This has led to cleaner outputs, fewer solvent-derived irritants in testing, and a noticeable drop in customer support queries about unexpected reactions.
Packaging and logistics often go unnoticed in desk-bound reviews but frequently impact product quality. We moved to inert glassware and pharmaceutical stoppers to cut down on leaching and volatility loss, reinforced by tests conducted after long shipping overland in variable climates. Every deviation from our approved carriers or vial batch gets logged and, if relevant, quarantined for detailed checking. These practices turn small annoyances—like sticky stoppers, uneven ampule filling, or weak label adhesion—into brief, fixable problems rather than recurring mistakes. Internally, every process change goes through open post-mortems so that future batches benefit from real, floor-level insight, not just theoretical improvement.
No matter how tight our production control, end-user feedback keeps our standards honest. Medical clinics often report subtle points—syringe withdrawal feel, post-injection soreness, even the clarity of written batch information. These details feed back into daily production meetings. Our plant has made changes based on things that would seem secondary: label font size, color contrasts for lot codes, adjusted injection volumes for viscosity, and visual design for easy inspection in field light, not just indoor labs.
Problems with shipment temperature spurred the adoption of phase change packaging in summer months—a non-trivial expense, but one that now lets us guarantee batch integrity on delivery even across shifting borders. Reports of rare post-injection reactions in animal studies led to re-examining trace oil impurities and a shift to dual-stage carrier oil filtration before sterile filtration, cutting visible particulates in final ampules to near zero. Every customer call, every inquiry from a hospital pharmacist or research leader, has helped us incrementally refine not just the output, but the way we work.
The most compelling part of this feedback is the long-term trust it creates. Returning buyers look for the same clarity, injection quality, and slow, steady release they recorded in last year’s lot—a challenge for many manufacturers, but something our plant has made a core virtue through both investment and operator diligence.
It’s easy to get lost in the technical weeds, but for users—clinicians, sports researchers, veterinarians—the final product means something direct. They count on each ampule to behave predictably across trials or treatment cycles. We hear this from endocrinologists tracking recovery of red cell lines, or veterinary practitioners managing musculoskeletal support in large animals. A single out-of-spec batch risks both immediate treatment failure and harm to cumulative research outcomes.
Researchers in Eastern Europe and Asia have increasingly favored our longer-ester nandrolone for its sustained release profile, reporting steadier response curves in preclinical testing. Compared to short esters or even other depot steroids, Nandrolone Undecylate brings greater inter-injection intervals, less cumulative site damage, and a slower taper—characteristics that, in complex studies, reduce confounders and researcher-induced deviations. From our end, requests for modified vials, alternate carrier oils, or batch-specific documentation follow these successes, pulling us further into a quality partnership with professionals who see beyond the label.
Even amid increased competition from generic large-scale suppliers, the focus on lot stability, low impurity levels, and consistent physical properties makes our Nandrolone Undecylate a return choice for those who have tried less carefully manufactured alternatives. Every year sees new challenges—regulatory shifts, alternate synthesis requests, even climate impacts on raw material supply—but the demand for a product that performs reliably, shot to shot, lot after lot, shows no sign of fading.
Manufacturing Nandrolone Undecylate isn’t a simple matter of following recipes from reference books or process charts. Each day brings its own puzzles—minor temperature drift, labeling misprints, human error in sample logging, or an unexpected surge in demand from researchers halfway around the globe. We built solutions by listening to customers while respecting our internal staff’s experience. Ongoing investment in both technology and people sustains product trust and shapes standards that competitors reference but rarely match.
Working with this product for years sharpens an appreciation for process, detail, and, most importantly, accountability. Those who’ve spent enough time compounding and testing hormone esters witness that nothing substitutes for hands-on inspection, open communication with clients, and a stubborn insistence on quality. These build the confidence that the product injected today will perform as well as it did in last year’s trial, supported by a production culture that values learning as much as output. Nandrolone Undecylate may, on the surface, look like just another ampule, yet each batch carries with it the effort, adaptation, and knowledge of those who make it.
In the chemical world, the difference between manufacturer and mere bottler lies in the sum of such lessons and the willingness to put quality above convenience. Our Nandrolone Undecylate reflects these values: a product shaped by expertise, care, and readiness to adapt so that every vial leaves our loading dock ready for real-world outcomes, not just a place on a shelf.